Belhaven Biopharma
Research Triangle Park, United States (US) · Health and Medical
Do your work at Belhaven Biopharma?
Claim this profile to manage your company.
Verified by Enterprise League
Data quality
Complete · Accuracy
Last verified
May 2026
Belhaven Biopharma is a US-based biotechnology company specializing in the development of innovative dry powder nasal medicines for emergency treatment of severe allergic reactions and anaphylaxis.We are dedicated to improving global access to life-saving epinephrine treatments, particularly in underserved regions where traditional auto-injectors are unavailable or unreliable.Our flagship product, Nasdepi®, represents a significant advancement in allergy care, offering a needle-free, heat-stable, and user-friendly alternative to existing epinephrine delivery methods.
Overview
We are dedicated to improving global access to life-saving epinephrine treatments, particularly in underserved regions where traditional auto-injectors are unavailable or unreliable.
Our flagship product, Nasdepi®, represents a significant advancement in allergy care, offering a needle-free, heat-stable, and user-friendly alternative to existing epinephrine delivery methods. Nasdepi® is engineered for rapid absorption, simple administration, and long shelf life, addressing critical barriers to effective treatment.
Belhaven Biopharma’s mission is to empower individuals and families facing severe allergies with a reliable, accessible, and pain-free solution, ultimately reducing the risk of life-threatening anaphylaxis events worldwide.
Contact Details
Research Triangle Park, United States (US)
Founded
2021
Company Type
Private Limited Company
Employees
2-10
Categories
Keywords
#dry powder formulation
#nasal drug delivery
Companies teams usually look at after Belhaven Biopharma
Comparing a few options usually leads to better decisions
Save companies to compare later. Useful when sharing options with your team
This is how your company profile looks to others.